PUBLISHED DATE : Jan 2020 | Pages : 263
| Up to $500 off | Until Oct 2021 |
Fill out your details & get your free sample
Cardiac Pacemaker Market Size, Share, & Trends Analysis Report by Products (MRI-conditional and Traditional), Technology (Dual-Chamber, Single Chamber, and Biventricular Pacemakers/CRT-P), Implantability (Implantable and External), End-Users (Hospitals, SSC, and ASC), and Geography (North America, Europe, APAC, Latin America, and Middle East & Africa), Industry Analysis, Price Trends, Growth Potential, Competitive Analysis & Forecast, 2020-2025
263 Pages
37 Tables
159 Charts
6 Regions
17 Countries
12 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (Revenue) | USD 5 BILLION (2025) |
| CAGR | 2% (2020-2025) |
| Base Year | 2019 |
| Forecast Year | 2020 - 2025 |
| Market Segments | Products (MRI-conditional and Traditional), Technology (Dual-Chamber, Single Chamber, and Biventricular Pacemakers/CRT-P), Implantability (Implantable and External), End-Users (Hospitals, SSC, and ASC) |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, Germany, France, UK, Spain, Italy, Japan, China, India, South Korea, Australia, Brazil, Turkey, South Africa, Saudi Arabia, and Mexico |
The global cardiac pacemaker market size will reach USD 5 billion in 2025, growing at a CAGR of 2% during the forecast period. The growing prevalence of abnormal cardiac rhythm disorders, coupled with the increasing elderly population, which is prone to arrhythmias, is expected to drive the market. Advancements in technology and engineering provide clinicians innovative ways to care for the aging population. Cardiac pacing, particularly, has witnessed a series of game-changing technologies in the past several years spurred by low-power electronics, high-density batteries, and innovative software designs. Such innovations are expected to drive the market.
Several government bodies and private organizations are involved in spreading awareness, information, and support for cardiovascular diseases, thereby affecting the market positively. The growing patient population with arrhythmias globally requires advanced and cost-effective treatment options with minimal side-effects and complications.
This research report includes detailed segmentation by
The MRI-conditional segment accounted for over 50% of the cardiac pacemaker market share in 2019 and is expected to grow at a faster rate in the near future as several pieces of research have confirmed that over 70% of patients implanted require MRI scan during their lifespan. Many public organizations recommend implanting MRI-conditional ones to minimize the risk associated with MRI scans. Moreover, many public and private insurance companies offer reimbursement coverage for MRI scans for patients implanted with MRI-conditional devices, which increase affordability, thereby driving the market. Advancements in technology are influencing the market positively as traditional pacemakers are expected to malfunction, thus leading to complications. Hence, the increased complications related to conventional devices are likely to decrease the share of this equipment.
Dual-chamber technology is accounted for the major market share. This type of technology is likely to continue its dominance due to the increasing number of patients with abnormal heart rhythm defects. These models are highly efficient in treating cardiac arrhythmias. Besides, the number of vendors offering such pacemakers is growing as many patients prefer this type.
Single chamber devices help to minimize the risk of infections related to MRI scans and are cost-effective. The demand for single chamber ones is increasing in developing and low-income countries.
Biventricular pacemakers/CRT-P is growing at a rapid pace as these devices minimize failure chances and efficiently treat rhythm disorders. All these advantages, along with increased public and private reimbursement coverage, are expected to boost the segment.
Implantable CPs are growing at a rapid pace due to the increase in the geriatric population and the rise in arrhythmia and abnormal cardiovascular disorder prevalence rates. Advancements in technology, including the introduction of leadless, MRI-compatible, and other remote monitoring pacemaker devices, have fueled the demand for implantable ones, and the segment is expected to contribute significantly to the market. External CPs are expected to grow at a steady pace due to the increased number of patients opting for temporary cardiac devices.
Hospitals are the major end-user segment as a significant number of patients prefer to undergo surgeries in these settings due to better reimbursement policies. The growing aging population and the increasing prevalence of abnormal cardiovascular disorders are the other major factors contributing to the increase in implantation in hospitals.
Specialty cardiology centers (SCCs) are expected to grow at a significant rate owing to the availability of sophisticated infrastructure and the availability of advanced technology cardiac pacemakers these centers. Besides, SCCs have a high presence of highly skilled cardiovascular surgeons.
Ambulatory surgery centers (ASCs) are cost-effective clinics and offer high-quality care with minimal indirect treatment costs. These centers are equipped with advanced diagnostic and treatment equipment without complex administrative procedures. Such factors are likely to boost the prospects of the market.
North America accounts for a major share in the global cardiac pacemaker market. It is expected to grow at a steady rate on account of the growing volume of surgeries for treating several abnormal heart rhythms and the availability of advanced healthcare infrastructure and constant technological innovations. Europe is likely to grow at a healthy rate due to the accessibility of advanced healthcare services, especially for heart valve repair and replacement procedures. Also, the increasing incidence of abnormal heart rhythm, the rapid adoption of sophisticated cardiac pacemakers, and high healthcare expenditures are projected to increase the European market. Factors responsible for the growth of APAC are vendors' initiatives in spreading awareness and the rise in abnormal rhythm incidences due to change in living patterns, stress, and old age.
The global cardiac pacemaker market share is highly competitive and characterized by the presence of vendors offering a wide range of advanced and innovative CPs. The market is witnessing rapid technological advancements and significantly affected by new product launches. All the companies that primarily derive revenue from cardiac pacemakers are expected to grow at a favorable rate. Multiple product launches and diversified product portfolio is likely to fuel their growth in recent years. Going forward, R&D activities are expected to become crucial for companies to maintain revenue growth in the coming years. Global players with their huge infrastructure, marketing strategies, distribution network, and R&D support are likely to expand their footprint in the market. Thus, small and emerging vendors find it increasingly difficult to compete with them in terms of innovation, brand image, technology, and price.
Product
Technology
Implantability
End-user
Geography
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
Fill out your details & get your free sample
DAYS
HOURS
MINUTES
SECONDS
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
Want to know more about the report or any specific requirement?
Click to Email +1-312-235-2040
